Source: MarketScreener

Valneva: Valneva to Conduct Investor and Partnering Meetings during the 38th Annual J.P. Morgan Healthcare Conference

(marketscreener.com) Saint-Herblain (France), December 5, 2019 - Valneva SE ("Valneva"), announced today that its management team including Thomas Lingelbach, CEO, David Lawrence, CFO, and Franck Grimaud, CBO, will hold media, investor and partnering meetings during the 38th Annual J.P. Morgan Healthcare Conference, Jan. 12 - Jan. 16,...http://www.marketscreener.com/VALNEVA-SE-54466/news/Valneva-to-Conduct-Investor-and-Partnering-Meetings-during-the-38th-Annual-J-P-Morgan-Healthcare-Co-29687205/?utm_medium=RSS&utm_content=20191205

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue

Employees

Thomas Lingelbach's photo - President & CEO of Valneva

President & CEO

Thomas Lingelbach

CEO Approval Rating

88/100

Valneva is a biotechnology company that develops and commercializes vaccines for the treatment of infectious diseases.

Va...
Read more